Nuwellis, Inc.
$1.16
0%
2026-04-21 08:31:00
www.nuwellis.com
NCM: NUWE
Explore Nuwellis, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.85 M
Current Price
$1.16
52W High / Low
$45.42 / $0.96
Stock P/E
—
Book Value
$1.56
Dividend Yield
—
ROCE
-359.88%
ROE
-3.83%
Face Value
—
EPS
$-25.39
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
38
Beta
0.08
Debt / Equity
12.47
Current Ratio
1.71
Quick Ratio
1.08
Forward P/E
-0.42
Price / Sales
0.35
Enterprise Value
$1.76 M
EV / EBITDA
-0.16
EV / Revenue
0.21
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | CONMED Corporation | $39.68 | 25.61 | $1.2 B | 2.05% | 5.1% | 4.71% | $61.08 / $33.21 | $33.36 |
| 2. | CapsoVision, Inc. | $6.01 | — | $299.53 M | — | -185.75% | -1.85% | $15.37 / $3.43 | $0.28 |
| 3. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
| 4. | Lifeward Ltd. | $7.52 | — | $11.49 M | — | -155.52% | -1.46% | $18.6 / $4.14 | $5.52 |
| 5. | Adagio Medical Holdings, Inc. | $1.53 | — | $34.43 M | — | -62.51% | -1.55% | $2.87 / $0.74 | $0.56 |
| 6. | SANUWAVE Health, Inc. | $19.94 | 14.99 | $177.13 M | — | 25.36% | -166.66% | $46.59 / $16.27 | $0.19 |
| 7. | Beyond Air, Inc. | $0.55 | — | $6.22 M | — | -177.71% | -2.4% | $5.84 / $0.43 | $0.96 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 2.42 M | 2.22 M | 1.73 M | 1.9 M | 2.32 M | — |
| Operating Profit | -2.44 M | -2.7 M | -2.91 M | -3.06 M | -2.39 M | — |
| Net Profit | -2.42 M | 0.47 M | -12.55 M | -3.01 M | -1.47 M | — |
| EPS in Rs | -0.92 | 0.18 | -4.76 | -1.14 | -0.56 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 8.27 M | 8.74 M | 8.86 M | 8.54 M |
| Operating Profit | -11.11 M | -10.99 M | -17.63 M | -17.17 M |
| Net Profit | -17.52 M | -11.16 M | -20.21 M | -14.53 M |
| EPS in Rs | -6.65 | -4.24 | -7.67 | -5.51 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 6.12 M | 9.86 M | 9.77 M | 24.67 M |
| Total Liabilities | 3.49 M | 3.33 M | 6.56 M | 12.32 M |
| Equity | 2.63 M | 6.53 M | 3.21 M | 12.36 M |
| Current Assets | 5.19 M | 8.86 M | 8.21 M | 22.77 M |
| Current Liabilities | 3.03 M | 2.56 M | 3.17 M | 4.69 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -10.81 M | -9.59 M | -17.94 M | -15.15 M |
| Investing CF | -0.09 M | -0.06 M | 0.33 M | 14.73 M |
| Financing CF | 6.94 M | 10.96 M | 3.68 M | 9.42 M |
| Free CF | -10.9 M | -9.65 M | -18.18 M | -15.27 M |
| Capex | -0.09 M | -0.06 M | -0.25 M | -0.12 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -1.4% | 3.76% | — | — |
| Earnings Growth % | 44.75% | -39.13% | — | — |
| Profit Margin % | -127.75% | -227.99% | -170.02% | — |
| Operating Margin % | -125.72% | -198.89% | -200.99% | — |
| Gross Margin % | 64.94% | 56.22% | 55.66% | — |
| EBITDA Margin % | -59.99% | -184.52% | -57.32% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-07-07 | 1:0.0238095 |
| 2024-06-28 | 1:0.0285714 |
| 2022-12-12 | 1:0.01 |